LENZING AKTIENGESELLSCHAFT

LENZING AKTIENGESELLSCHAFT has been granted 69 US utility patents between 2015 and 2025, placing LENZING AKTIENGESELLSCHAFT at rank #5,022 across all assignees tracked by PlainPatent. This portfolio spans 52 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in D01F (CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS). As a Foreign Corporation, LENZING AKTIENGESELLSCHAFT is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 60.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 52 grants, compared with 17 in the 2015–2019 window — a +206% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. LENZING AKTIENGESELLSCHAFT's 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 52 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark LENZING AKTIENGESELLSCHAFT against peers pursuing similar technology classes.